Expectations trend
FY2028 · fiscal year ending 2028-10-31 · fmp
$3.97 → $3.97 · observed estimates
Hovnanian Enterprises, Inc. (HOV)
NYSEConsumer DiscretionaryResidential ConstructionSnapshot 2026-11-04
$104.83-5.17%
Close 2026-11-05 · 1-day change
NYSEConsumer DiscretionaryResidential ConstructionSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for HOV yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Stable debt levels after refinancing | Debt levels are stable after refinancing. | Intact | Significant new debt issuance increasing leverage | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-10-31 · fmp
$3.97 → $3.97 · observed estimates
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Dec 3, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a cyclical homebuilder, meaning results can move with housing and industry conditions, rather than a steady compounder. The long-term thesis is in a watch state: recent momentum improved, but performance remains below its industry cohort and execution is uneven.
HOV is expensive versus peers, with a 2.87 premium in the evidence snapshot, and the valuation model has low confidence. The snapshot says the fragility is justified by weak execution quality, but it does not show that the market has priced in the full combination of expensive valuation, weak execution, and turbulence.
Near term, revenue progress supports management’s Q4 goal, but adjusted gross margin is still below its guided range and adjusted EBITDA fell from Q2 to Q3. The recent earnings record is mixed, including a miss in August, and earnings quality is fragile; the stated miss risk is low, though results have been erratic.
The near-term test is whether Q4 revenue reaches $800M to $900M, adjusted gross margin reaches 15% to 16.5%, and adjusted EBITDA improves to $50M to $65M. Over the multi-year view, execution also depends on the next guidance update and whether sector bellwethers DHI, PHM, and LEN keep supporting or weaken the industry backdrop.
Over the next 1 to 3 years, the thesis rests on turning revenue growth into better margins and earnings, while managing elevated risk and an expensive valuation. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in Hovnanian Enterprises, Inc.'s published investment case. The stated target is >= $1.26 EPS. |
| Broken |
| EPS falls below zero for fiscal 2026 |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Gross margin between 14% and 15% | Gross margin holds around 14.5%. | Under Pressure | Gross margin falls below 13% next quarter | Gross margin: 13.12% FY2026-Q3; GAAP. Published target: 14.0% to 15.0%. Same fiscal period as the stored target. Aug 28, 202613.120726 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue near $700 million next quarter | Hovnanian keeps steady revenue near $700 million next quarter. | Intact | Revenue falls below $650 million next quarter | Revenue: $705.746M FY2026-Q3; GAAP. Published target: ~$700 million. Same fiscal period as the stored target. Aug 28, 2026705,746,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.18B → $3.18B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-11-01 | $3.97 | $3,175,500,000 | 1 / 1 |
| 2026-11-02 | $3.97 | $3,175,500,000 | 1 / 1 |
| 2026-11-03 | $3.97 | $3,175,500,000 | 1 / 1 |
| 2026-11-04 | $3.97 | $3,175,500,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 0 Hold · 1 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.